SUDAN PHARMACEUTICAL SALES MONITOR
Click here to download sample ,Sudan Q3 2019
INTRODUCTION:
THE ( SuPSM ) IS A QUARTERLY PUBLICATION DESIGNED TO ACCURATELY REFLECT THE QUANTITATIVE SALES OF PHARMACEUTICALS IN SUDAN (PRIVATE SECTOR) .
THIS STUDY PROVIDES INFORMATION ON THE ACTIVITY OF PHARMACEUTICAL COMPANIES AND SERVES AS A STATISTICAL TOOL OF ASSESSMENT OF SALES.
OBJECTIVE:
TO PROVIDE THE PHARMACEUTICAL COMPANIES OPERATING IN SUDAN WITH AN ACCURATE TOOL BY WHICH TO MEASURE THEIR SALES AND THE SALES OF THEIR COMPETITORS, ON A REGULAR BASIS.
METHODOLOGY:
1. SALES DATA IS COLLECTED DIRECTLY FROM THE MANUFACTURERS, AGENTS AND DISTRIBUTORS WORKING IN SUDAN AND THEIR FIGURES INSERTED INTO THE STUDY.
2. A REPRESENTATIVE SAMPLE OF 110 PHARMACIES THROUGHOUT SUDAN ARE VISITED ON A MONTHLY BASIS, AND THEIR PURCHASES OF PRODUCTS RECORDED.
THE DATA IS THEN CODED AND PROCESSED BY A COMPUTER PROGRAME. DURING THIS PROCESS STRICT QUALITY CONTROL MEASURES ARE APPLIED. AT THE FINAL STAGE THE DATA IS ANALYSED AND THEN PROJECTED TO THE NATIONAL LEVEL.
SELECTION OF PANEL PHARMACIES:
THE BASIS AND CRITERIA OF SELECTION WERE AS FOLLOWS:
1- PHARMACIES IN SUDAN WERE CATEGORIZED ACCORDING TO THEIR DAILY TURNOVER
( A+ ) PHARMACIES DAILY TURNOVER ABOVE USD 1000
( A ) PHARMACIES DAILY TURNOVER USD 600 – 1000
( B ) PHARMACIES DAILY TURNOVER USD 300 – 600
( C ) PHARMACIES DAILY TURNOVER BELOW USD 300
2- THE WEIGHTED AVERAGE OF EACH GROUP WAS CALCULATED AND FOUR SEPARATE PROJECTION FACTORS DETERMINED.
3- THE REGIONAL DISTRIBUTION OF PHARMACIES IN SUDAN.
CALCULATION OF VALUES:
THE PHARMACY PRICE IS THE PRICE LEVEL USED TO CALCULATE THE SD VALUE.
THE PHARMACY PURCHASE PRICE IS THE PRINTED UNIT APPEARING NEXT TO EACH PRODUCT.
PHARMACY UNIVERSE VS PANEL
REGION | UNIVERSE | SAMPLE |
KHARTUM |
350 |
25 |
UM DURMAN |
300 |
20 |
KHARTUM BAHRI |
300 |
20 |
MADANI |
150 |
10 |
PORT SUDAN |
50 |
4 |
ALUBAYAD |
90 |
7 |
COSTI |
50 |
4 |
OTHERS |
310 |
20 |
TOTAL |
1600 |
110 |
PRICE STRUCTURE
CIF | 100 |
+20% (Clearance + customs+ taxes) | 120 |
+15% Agent Margin | 135 (Pharmacies Purchase Price) |
+20% Pharmacies Margin | 169 (Public Purchase Price) |
Public Purchase Price X 0.798 | Pharmacy Purchase Price |